Generated June 3, 2026 at 8:33 PM ET
· Covers June 3 trading day
· 10 of 260 ready 8-Ks selected
· AI-assisted overview
The day featured strong earnings reports from Broadcom and CrowdStrike, with Broadcom reporting $22.2B in Q2 revenue and CrowdStrike posting a record $256M in net new ARR. Several M&A transactions were completed: Worthington Steel acquired a ~62% stake in Kloeckner & Co for €576M, FONAR finalized its going-private merger, and CXAI acquired EngineRoom for $4.6M. Glimpse Group appointed a new CEO and board and pivoted to Physical AI with a U.S. Navy partnership. Regulatory filings included Reed's receiving a NYSE American deficiency notice and Reliance Global Group regaining Nasdaq compliance, while Axsome settled all SUNOSI patent litigation and Corcept faced a declined DOJ intervention in a qui tam lawsuit.
leadership
positive
materiality 0.80
June 3, 2026, 8:45 AM ET
Glimpse Group appoints Tyler Gates CEO, Admiral Swift Chair; pivots to Physical AI with SpatialCore platform
- Tyler Gates appointed President, CEO and director; William Keneally appointed CFO, effective June 1, 2026.
- Admiral Scott Swift (USN Ret.) named Chair of the Board; Major General Pete Fesler and Brian Archer join board.
- SpatialCore platform introduced – open standards interoperability layer for Physical AI, deployed with U.S. Navy.
regulatory
negative
materiality 0.85
June 3, 2026, 4:15 PM ET
Reed's receives NYSE American deficiency notice; must submit compliance plan by June 28
- NYSE American notified Reed's on May 29, 2026 that it is below compliance with equity listing standards.
- Stockholders' equity was $2.7M as of March 31, 2026; net losses in five most recent fiscal years.
- Company must submit a compliance plan by June 28, 2026 and regain compliance by November 29, 2027.
WS
Worthington Steel, Inc.
M&A
positive
materiality 0.80
June 3, 2026, 6:47 AM ET
Worthington Steel completes €576M acquisition of Kloeckner & Co, secures ~62% stake
- Completed voluntary takeover of Kloeckner on June 3, 2026; holds ~62% of outstanding shares.
- Total aggregate consideration for tendered shares was €576,284,588 (~52.4M shares at €11.00 each).
- Intends to launch a public delisting tender offer at €11.00 per share for remaining Kloeckner shares.
M&A
neutral
materiality 1.00
June 3, 2026, 4:11 PM ET
FONAR completes going-private merger; stockholders receive $19.00–$10.50 per share
- Common and Class B common holders get $19.00/share; Class C gets $6.34; Class A preferred gets $10.50.
- Parent entered $20M term loan and $15M revolver with OceanFirst Bank to finance the transaction.
- Nasdaq listing suspended as of June 3, 2026; Form 15 will be filed to deregister common stock.
M&A
positive
materiality 0.75
June 3, 2026, 4:30 PM ET
CXAI acquires EngineRoom for $4.6M; annual revenue run-rate to exceed $12M
- Purchase price ~$4.6M: $2.99M cash, $1.15M earnout, $0.46M escrow; 100% of equity acquired.
- EngineRoom expected to generate ~$8.1M annual revenue (94% recurring) and ~$1.6M adj. EBITDA.
- Transaction expected to increase CXAI annualized revenue run-rate from ~$4M to >$12M.
AXSM
Axsome Therapeutics, Inc.
litigation
positive
materiality 0.75
June 3, 2026, 9:04 AM ET
Axsome settles all SUNOSI patent litigation; generic entry deferred to 2040
- Resolved all outstanding SUNOSI patent litigation with the last first-to-file generic applicant.
- Settlement grants five companies right to sell generic SUNOSI starting September 1, 2040 (if pediatric exclusivity) or March 1, 2040.
- No other patent litigation remains for SUNOSI.
EZRA
Reliance Global Group, Inc.
regulatory
positive
materiality 0.60
June 3, 2026, 9:15 AM ET
Reliance Global Group regains Nasdaq minimum bid price compliance
- Received Nasdaq notice on June 2, 2026 that bid price was >=$1.00 for 10 consecutive days May 18-June 1.
- Previously disclosed bid price non-compliance on Dec 12, 2025; now resolved and matter closed.
- CEO Ezra Beyman cites progress on strategic initiatives and Insurtech expansion as drivers.
CORT
CORCEPT THERAPEUTICS INC
litigation
negative
materiality 0.60
June 3, 2026, 8:00 AM ET
DOJ declines to intervene in Corcept qui tam lawsuit; relator files amended complaint
- DOJ filed Notice of Election to Decline Intervention on May 19, 2026 in case U.S. et al. ex rel. Stephen Elliott v. Corcept Therapeutics.
- DOJ, California Dept of Insurance, and named Plaintiff States all declined to intervene in the qui tam action.
- Relator served an amended complaint on June 2, 2026; company intends to vigorously defend.
earnings
positive
materiality 0.85
June 3, 2026, 4:21 PM ET
Broadcom Q2 FY2026 revenue $22.2B (+48% YoY); AI semi rev $10.8B (+143%); Q3 guide $29.4B (+84%)
- GAAP diluted EPS $1.91; non-GAAP diluted EPS $2.44; adjusted EBITDA $15.2B (69% of revenue).
- Free cash flow $10.3B, 46% of revenue; cash from operations $10.5B.
- AI semiconductor revenue $10.8B in Q2 (+143% YoY); Q3 AI semi rev expected $16.0B (+200% YoY).
CRWD
CrowdStrike Holdings, Inc.
earnings
positive
materiality 0.85
June 3, 2026, 4:06 PM ET
CrowdStrike Q1 FY27 net new ARR record $256M, up 32% YoY; guides FY27 net new ARR growth 27.7%
- Total revenue $1.39B (+26% YoY); subscription revenue $1.32B (+26% YoY).
- GAAP diluted EPS $0.11 vs. ($0.42) YoY; non-GAAP diluted EPS $1.10 vs. $0.73 YoY.
- Record operating cash flow $591M, free cash flow $468M; ARR $5.51B (+24% YoY).